resveratrol has been researched along with Cytokine Release Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, J; He, B; Liu, P; Nie, Q; Sun, M; Sun, W; Wang, C; Wang, F; Wen, J; Zhang, J | 1 |
1 other study(ies) available for resveratrol and Cytokine Release Syndrome
| Article | Year |
|---|---|
A novel mechanism of protection against isoproterenol-induced cardiac inflammation via regulation of the SIRT1/NRF2 signaling pathway with a natural SIRT1 agonist.
Topics: Adrenergic beta-Agonists; Animals; Antioxidants; Cardiotonic Agents; Cytokine Release Syndrome; Inflammasomes; Isoproterenol; Macrophage Activation; Male; Mice; Mice, Inbred C57BL; Myocarditis; NF-E2-Related Factor 2; Resveratrol; Signal Transduction; Sirtuin 1 | 2020 |